143 related articles for article (PubMed ID: 2183804)
1. Auranofin in the treatment of juvenile rheumatoid arthritis. Results of the USA-USSR double-blind, placebo-controlled trial. The USA Pediatric Rheumatology Collaborative Study Group. The USSR Cooperative Children's Study Group.
Giannini EH; Brewer EJ; Kuzmina N; Shaikov A; Wallin B
Arthritis Rheum; 1990 Apr; 33(4):466-76. PubMed ID: 2183804
[TBL] [Abstract][Full Text] [Related]
2. [The evaluation of the therapeutic efficacy of auranofin in juvenile rheumatoid arthritis (the results of Soviet-American research)].
Kuz'mina NN; Brue E; Shaĭkov AV; Isaeva LA; Shakhbazian IE; Giannini E; Iakovleva AA; Puodzhiunene EP; Vorontsov IM; Astrauskene DS
Ter Arkh; 1990; 62(5):38-41. PubMed ID: 2204140
[TBL] [Abstract][Full Text] [Related]
3. Auranofin (SK&F) in early rheumatoid arthritis: results from a 24-month double-blind, placebo-controlled study. Effect on clinical and biochemical assessments.
Johnsen V; Borg G; Trang LE; Berg E; Brodin U
Scand J Rheumatol; 1989; 18(5):251-60. PubMed ID: 2688083
[TBL] [Abstract][Full Text] [Related]
4. A double-blind placebo-controlled study of auranofin in patients with psoriatic arthritis.
Carette S; Calin A; McCafferty JP; Wallin BA
Arthritis Rheum; 1989 Feb; 32(2):158-65. PubMed ID: 2645874
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group.
Giannini EH; Brewer EJ; Kuzmina N; Shaikov A; Maximov A; Vorontsov I; Fink CW; Newman AJ; Cassidy JT; Zemel LS
N Engl J Med; 1992 Apr; 326(16):1043-9. PubMed ID: 1549149
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and safety of auranofin in the treatment of juvenile rheumatoid arthritis. A long-term open study.
Marcolongo R; Mathieu A; Pala R; Giordano N; Fioravanti A; Panzarasa R
Arthritis Rheum; 1988 Aug; 31(8):979-83. PubMed ID: 3044374
[TBL] [Abstract][Full Text] [Related]
7. Auranofin therapy in juvenile rheumatoid arthritis: a 48-week phase II study.
Kvien TK; Høyeraal HM; Sandstad B; Kass E
Scand J Rheumatol Suppl; 1986; 63():79-83. PubMed ID: 3474778
[TBL] [Abstract][Full Text] [Related]
8. Auranofin in the treatment of juvenile rheumatoid arthritis.
Giannini EH; Brewer EJ; Person DA
J Pediatr; 1983 Jan; 102(1):138-41. PubMed ID: 6401327
[TBL] [Abstract][Full Text] [Related]
9. Early experiences with auranofin in juvenile rheumatoid arthritis.
Brewer EJ; Giannini EH; Person DA
Am J Med; 1983 Dec; 75(6A):152-6. PubMed ID: 6419599
[TBL] [Abstract][Full Text] [Related]
10. Low-dose methotrexate compared with auranofin in adult rheumatoid arthritis. A thirty-six-week, double-blind trial.
Weinblatt ME; Kaplan H; Germain BF; Merriman RC; Solomon SD; Wall B; Anderson L; Block S; Irby R; Wolfe F
Arthritis Rheum; 1990 Mar; 33(3):330-8. PubMed ID: 2180405
[TBL] [Abstract][Full Text] [Related]
11. Longterm auranofin therapy in patients with juvenile rheumatoid arthritis.
Giannini EH; Brewer EJ; Person DA; He XH
J Rheumatol; 1986 Aug; 13(4):768-70. PubMed ID: 3534260
[TBL] [Abstract][Full Text] [Related]
12. Auranofin therapy for juvenile rheumatoid arthritis: results of the five-year open label extension trial.
Giannini EH; Barron KS; Spencer CH; Person DA; Baum J; Bernstein BH; Kredich DW; Jacobs JC; Zemel LS; Gibbas D
J Rheumatol; 1991 Aug; 18(8):1240-2. PubMed ID: 1941832
[TBL] [Abstract][Full Text] [Related]
13. Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study.
Borg G; Allander E; Lund B; Berg E; Brodin U; Pettersson H; Trang L
J Rheumatol; 1988 Dec; 15(12):1747-54. PubMed ID: 14552308
[TBL] [Abstract][Full Text] [Related]
14. A placebo-controlled multicenter study of auranofin in the treatment of patients with corticosteroid-dependent asthma. Auranofin Multicenter Drug Trial.
Bernstein IL; Bernstein DI; Dubb JW; Faiferman I; Wallin B
J Allergy Clin Immunol; 1996 Aug; 98(2):317-24. PubMed ID: 8757209
[TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulin in the treatment of systemic juvenile rheumatoid arthritis: a randomized placebo controlled trial. Pediatric Rheumatology Collaborative Study Group.
Silverman ED; Cawkwell GD; Lovell DJ; Laxer RM; Lehman TJ; Passo MH; Zemel LS; Giannini EH
J Rheumatol; 1994 Dec; 21(12):2353-8. PubMed ID: 7699642
[TBL] [Abstract][Full Text] [Related]
16. Auranofin in juvenile rheumatoid arthritis. An open label, non-controlled study.
Garcia-Morteo O; Suarez-Almazor ME; Maldonado-Cocco JA; Cuttica R; Abate S
Clin Rheumatol; 1984 Jun; 3(2):223-7. PubMed ID: 6432407
[TBL] [Abstract][Full Text] [Related]
17. A multicentre double-blind comparison of auranofin, intramuscular gold thiomalate and placebo in patients with psoriatic arthritis.
Palit J; Hill J; Capell HA; Carey J; Daunt SO; Cawley MI; Bird HA; Nuki G
Br J Rheumatol; 1990 Aug; 29(4):280-3. PubMed ID: 2116206
[TBL] [Abstract][Full Text] [Related]
18. Auranofin is safe and superior to placebo in elderly-onset rheumatoid arthritis.
Glennås A; Kvien TK; Andrup O; Clarke-Jenssen O; Karstensen B; Brodin U
Br J Rheumatol; 1997 Aug; 36(8):870-7. PubMed ID: 9291856
[TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy and safety of advanced drug therapy in children with juvenile rheumatoid arthritis.
Giannini EH; Cassidy JT; Brewer EJ; Shaikov A; Maximov A; Kuzmina N
Semin Arthritis Rheum; 1993 Aug; 23(1):34-46. PubMed ID: 8235664
[TBL] [Abstract][Full Text] [Related]
20. Auranofin and gold sodium thiomalate in the treatment of rheumatoid arthritis: a one-year, double-blind, comparative multicenter study.
Schattenkirchner M; Bröll H; Kaik B; Müller-Fassbender H; Rau R; Zeidler H
Klin Wochenschr; 1988 Feb; 66(4):167-74. PubMed ID: 3131571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
